BNP Paribas Financial Markets’s AYTU BioPharma AYTU Stock Holding History

BNP Paribas Financial Markets’s Portfolio AYTU Stock Details AYTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$63	Hold	23	–	–	﹤0.01%	5710
2025 Q4	$60	Hold	23	–	–	﹤0.01%	5636
2025 Q3	$43	Hold	23	–	–	﹤0.01%	5477
2025 Q2	$50	Hold	23	–	–	﹤0.01%	5356
2025 Q1	$28	Hold	23	–	–	﹤0.01%	5310
2024 Q4	$39	Buy	+23	New	+$42	﹤0.01%	5326
2022 Q4	–	Sell	-26	Closed	-$97	–	4097
2022 Q3	$97	Buy	+26	New	+$197	﹤0.01%	4650
2020 Q4	–	Sell	-35	Closed	-$8.34K	–	4145
2020 Q3	$8.34K	Buy	35 +31	+775%	+$7.97K	﹤0.01%	3976
2020 Q2	$1.22K	Buy	+4	New	+$1.21K	﹤0.01%	4191

Other funds holding AYTU

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CAM

Crown Advisors Management Larkspur, California $151M AUM 73.11% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PAP

Persistent Asset Partners Hong Kong $268M AUM 158.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BNP Paribas Financial Markets's AYTU Position: Q1 2026 in Review

BNP Paribas Financial Markets held its AYTU BioPharma (AYTU) position steady in Q1 2026 at 23 shares worth $63. The position accounts for ﹤0.01% of the portfolio, ranked #5710.

BNP Paribas Financial Markets first reported a position in AYTU in Q2 2020 and has held it in 9 quarters since. The position peaked at $8.34K in Q3 2020. 37 funds tracked by Wall St. Rank hold AYTU as of Q1 2026.

BNP Paribas Financial Markets held 23 shares of AYTU BioPharma worth $63 as of Q1 2026.
BNP Paribas Financial Markets left its AYTU BioPharma share count unchanged in Q1 2026.
AYTU BioPharma made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5710 holding.
BNP Paribas Financial Markets first reported a position in AYTU BioPharma in Q2 2020 and has held it in 9 quarters since.
BNP Paribas Financial Markets's AYTU BioPharma position peaked at $8.34K in Q3 2020.
37 funds tracked by Wall St. Rank held AYTU BioPharma as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.